Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer
Matthew Drill, Nigel C. Jones, Martin Hunn, et al.
Purinergic Signalling (2021) Vol. 17, Iss. 2, pp. 215-227
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Beyond Amyloid and Tau: The Critical Role of Microglia in Alzheimer’s Disease Therapeutics
Daniela Dias, Renato Socodato
Biomedicines (2025) Vol. 13, Iss. 2, pp. 279-279
Open Access | Times Cited: 2
The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications
John Charles Rotondo, Chiara Mazziotta, Carmen Lanzillotti, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1116-1116
Open Access | Times Cited: 65
Health benefits of astaxanthin against age-related diseases of multiple organs: A comprehensive review
Phaniendra Alugoju, V. K. D. Krishna Swamy, Naga Venkata Anusha Anthikapalli, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 31, pp. 10709-10774
Closed Access | Times Cited: 62
Signalling by extracellular nucleotides in health and disease
Valentina Vultaggio-Poma, Simonetta Falzoni, Giada Salvi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2022) Vol. 1869, Iss. 5, pp. 119237-119237
Open Access | Times Cited: 42
cGAMP the travelling messenger
Henry T.W. Blest, Lise Chauveau
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Supramolecular Hydrogel with Ultra‐Rapid Cell‐Mediated Network Adaptation for Enhancing Cellular Metabolic Energetics and Tissue Regeneration
Zhuo Li, Boguang Yang, Zhengmeng Yang, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 14
Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy
Wenpan Li, Yanhao Jiang, Jianqin Lu
International Journal of Pharmaceutics (2023) Vol. 634, pp. 122655-122655
Open Access | Times Cited: 19
Purine and purinergic receptors in health and disease
Yanling Ai, Hengyi Wang, Lu Liu, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 15
Hypoxia‐inducible factor 1 alpha (HIF‐1α) stimulated and P2X7 receptor activated by COVID-19, as a potential therapeutic target and risk factor for epilepsy
Hamidreza Zalpoor, Abdullatif Akbari, Mohsen Nabi‐Afjadi, et al.
Human Cell (2022) Vol. 35, Iss. 5, pp. 1338-1345
Open Access | Times Cited: 20
The Coming of Age of the P2X7 Receptor in Diagnostic Medicine
Francesco Di Virgilio, Valentina Vultaggio-Poma, Simonetta Falzoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9465-9465
Open Access | Times Cited: 12
Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms
Ru Li, Yongya Wu, Yan Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116040-116040
Closed Access | Times Cited: 11
The impact of the P2X7 receptor on the tumor immune microenvironment and its effects on tumor progression
Yu-ting Zou, Jinyuan Li, Jun-yi Chai, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 707, pp. 149513-149513
Closed Access | Times Cited: 4
Unraveling the role of the P2X7 receptor in cancer radioresistance: Molecular insights and therapeutic implications
Seyedeh Nasibeh Mousavikia, Maryam Moghaddam Matin, Mohammad Taghi Bahreyni Tossi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2025) Vol. 1872, Iss. 3, pp. 119910-119910
Closed Access
Effects of nanoflubendazole and purinergic signaling modulation in overcoming neuroblastoma chemoresistance
Renata Siqueira de Mello, Carolina Adriane Bento, Rafael de Oliveira Faria, et al.
Purinergic Signalling (2025)
Closed Access
Pharmacological Monotherapy for Depressive Disorders: Current and Future, a Narrative Review
Keming Gao, Evrim Bayrak Oruc, Buket Koparal
Medicina (2025) Vol. 61, Iss. 4, pp. 558-558
Open Access
AK1780, a selective P2X7 receptor antagonist with high central nervous system penetration, exhibits analgesic effect in rat neuropathic pain model
Naomi Shinotsuka, Hirotomo Shimizu, Takayuki Komatsu, et al.
Journal of Pain (2025), pp. 105380-105380
Closed Access
Cancer Metabostemness and Metabolic Reprogramming via P2X7 Receptor
Izadora Lorrany Alves Rabelo, Vanessa Fernandes Arnaud-Sampaio, Elena Adinolfi, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1782-1782
Open Access | Times Cited: 22
The role of P2X7 receptor in infection and metabolism: Based on inflammation and immunity
Xiaoyu Cai, Yao Yao, Fei Teng, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108297-108297
Closed Access | Times Cited: 21
Tumour immune escape via P2X7 receptor signalling
Ricardo M. Sainz, Jorge Humberto Rodríguez-Quintero, María C. Maldifassi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Vitamin C Inhibits Lipopolysaccharide-Induced Hyperinflammatory State of Chronic Myeloid Leukemia Cells through Purinergic Signaling and Autophagy
Daniela A. Pires, Maysa Alves Rodrigues Brandão-Rangel, Anamei Silva-Reis, et al.
Nutrients (2024) Vol. 16, Iss. 3, pp. 383-383
Open Access | Times Cited: 2
A patent review of P2X7 receptor antagonists to treat inflammatory diseases (2018 – present)
Jamshed Iqbal, Sehrish Bano, Imtiaz Khan, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 4, pp. 263-271
Closed Access | Times Cited: 2
P2X7 receptor antagonism by AZ10606120 significantly depletes glioblastoma cancer stem cells in vitro
Liyen Katrina Kan, Matthew Drill, Padmakrishnan C. Jayakrishnan, et al.
Brain Research Bulletin (2024) Vol. 215, pp. 110996-110996
Open Access | Times Cited: 2
Role of the P2X7 receptor in breast cancer progression
Yanan Du, Yahui Cao, Wei Song, et al.
Purinergic Signalling (2024)
Closed Access | Times Cited: 2
Glycosides for Peripheral Neuropathic Pain: A Potential Medicinal Components
Miaomiao Tian, Yuxiang Li, Shan Liu, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 255-255
Open Access | Times Cited: 13
ATP ion channel P2X7 receptor as a regulatory molecule in the progression of colorectal cancer
Cheng Zuo, Yongsheng Xu, Pengfei He, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115877-115877
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top